These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|||||||
(State or Other Jurisdiction of
Incorporation or Organization) |
(I.R.S. Employer
Identification No.) |
Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||||||||
|
|
|
|
Accelerated filer
¨
|
Emerging growth company
|
||||||
Non-accelerated filer
¨
|
Smaller reporting company
|
Page
Number |
|||||||||||
Item 1. | |||||||||||
Item 2. | |||||||||||
Item 3. | |||||||||||
Item 4. | |||||||||||
Item 1. | |||||||||||
Item 1A. | |||||||||||
Item 2. | |||||||||||
Item 3. | |||||||||||
Item 4. | |||||||||||
Item 5. | |||||||||||
Item 6. | |||||||||||
Item 1. | CONSOLIDATED FINANCIAL STATEMENTS |
(Unaudited) | |||||||||||
March 2,
2025 |
December 1,
2024 |
||||||||||
(Dollars in millions) | |||||||||||
ASSETS | |||||||||||
Current Assets: | |||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Trade receivables, net |
|
|
|||||||||
Inventories |
|
|
|||||||||
Other current assets |
|
|
|||||||||
Current assets held for sale
|
|
|
|||||||||
Total current assets |
|
|
|||||||||
Property, plant and equipment, net |
|
|
|||||||||
Goodwill |
|
|
|||||||||
Other intangible assets, net |
|
|
|||||||||
Deferred tax assets, net |
|
|
|||||||||
Operating lease right-of-use assets, net |
|
|
|||||||||
Other non-current assets |
|
|
|||||||||
Non-current assets held for sale
|
|
|
|||||||||
Total assets | $ |
|
$ |
|
|||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current Liabilities: | |||||||||||
Accounts payable | $ |
|
$ |
|
|||||||
Accrued salaries, wages and employee benefits |
|
|
|||||||||
Accrued sales returns and allowances |
|
|
|||||||||
Short-term operating lease liabilities |
|
|
|||||||||
Other accrued liabilities |
|
|
|||||||||
Current liabilities held for sale
|
|
|
|||||||||
Total current liabilities |
|
|
|||||||||
Long-term debt |
|
|
|||||||||
Long-term operating lease liabilities |
|
|
|||||||||
Long-term employee related benefits and other liabilities |
|
|
|||||||||
Long-term liabilities held for sale
|
|
|
|||||||||
Total liabilities |
|
|
|||||||||
Commitments and contingencies |
|
|
|||||||||
Stockholders’ Equity: | |||||||||||
Common stock — $
|
|
|
|||||||||
Additional paid-in capital |
|
|
|||||||||
Retained earnings |
|
|
|||||||||
Accumulated other comprehensive loss |
(
|
(
|
|||||||||
Total stockholders’ equity |
|
|
|||||||||
Total liabilities and stockholders’ equity | $ |
|
$ |
|
Three Months Ended | |||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||
(Dollars in millions, except per share amounts)
(Unaudited) |
|||||||||||||||||||||||
Net revenues | $ |
|
$ |
|
|||||||||||||||||||
Cost of goods sold |
|
|
|||||||||||||||||||||
Gross profit |
|
|
|||||||||||||||||||||
Selling, general and administrative expenses |
|
|
|||||||||||||||||||||
Restructuring charges, net |
|
|
|||||||||||||||||||||
Operating income
|
|
|
|||||||||||||||||||||
Interest expense |
(
|
(
|
|||||||||||||||||||||
Other expense, net
|
(
|
(
|
|||||||||||||||||||||
Income (loss) from continuing operations before income taxes
|
|
(
|
|||||||||||||||||||||
Income tax expense (benefit)
|
|
(
|
|||||||||||||||||||||
Net income (loss) from continuing operations
|
|
(
|
|||||||||||||||||||||
Net income (loss) from discontinued operations, net of taxes
|
(
|
(
|
|||||||||||||||||||||
Net income (loss)
|
$ |
|
$ |
(
|
|||||||||||||||||||
Earnings (loss) per common share:
|
|||||||||||||||||||||||
Continuing operations - Basic
|
$ |
|
$ |
(
|
|||||||||||||||||||
Discontinued operations - Basic
|
(
|
|
|||||||||||||||||||||
Net income (loss) - Basic
|
$ |
|
$ |
(
|
|||||||||||||||||||
Continuing operations - Diluted
|
$ |
|
$ |
(
|
|||||||||||||||||||
Discontinued operations - Diluted
|
(
|
|
|||||||||||||||||||||
Net income (loss) - Diluted
|
$ |
|
$ |
(
|
|||||||||||||||||||
Weighted-average common shares outstanding: | |||||||||||||||||||||||
Basic |
|
|
|||||||||||||||||||||
Diluted |
|
|
Three Months Ended | |||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||
(Dollars in millions)
(Unaudited) |
|||||||||||||||||||||||
Net income (loss)
|
$ |
|
$ |
(
|
|||||||||||||||||||
Other comprehensive income (loss), before related income taxes:
|
|||||||||||||||||||||||
Pension and postretirement benefits
|
|
|
|||||||||||||||||||||
Derivative instruments
|
|
|
|||||||||||||||||||||
Foreign currency translation gains (losses)
|
(
|
(
|
|||||||||||||||||||||
Total other comprehensive income (loss), before related income taxes
|
|
|
|||||||||||||||||||||
Income tax benefit (expense) related to items of other comprehensive income (loss)
|
(
|
(
|
|||||||||||||||||||||
Comprehensive income (loss), net of taxes
|
$ |
|
$ |
(
|
Three Months Ended March 2, 2025 | |||||||||||||||||||||||||||||||||||
Class A
& Class B
Common
Stock
(In Shares)
|
Class A
& Class B Common Stock |
Additional
Paid-In Capital |
Retained
Earnings |
Accumulated Other
Comprehensive Loss |
Total
Stockholders’ Equity
|
||||||||||||||||||||||||||||||
(Shares & Dollars in millions)
(Unaudited)
|
|||||||||||||||||||||||||||||||||||
Balance at December 1, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||
Net income
|
— | — | — |
|
— |
|
|||||||||||||||||||||||||||||
Other comprehensive income, net of tax
|
— | — | — | — |
|
|
|||||||||||||||||||||||||||||
Stock-based compensation and dividends, net |
|
— |
|
|
— |
|
|||||||||||||||||||||||||||||
Employee stock purchase plan |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
Repurchase of common stock |
(
|
— | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||
Tax withholdings on equity awards | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
Cash dividends declared ($
|
— | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||
Balance at March 2, 2025
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
Three Months Ended February 25, 2024 | |||||||||||||||||||||||||||||||||||
Class A
& Class B
Common
Stock
(In Shares)
|
Class A
& Class B Common Stock |
Additional
Paid-In Capital |
Retained
Earnings |
Accumulated Other
Comprehensive Loss |
Total
Stockholders’ Equity
|
||||||||||||||||||||||||||||||
(Shares & Dollars in millions)
(Unaudited)
|
|||||||||||||||||||||||||||||||||||
Balance at November 26, 2023
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||
Net loss
|
— | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||
Other comprehensive income, net of tax
|
— | — | — | — |
|
|
|||||||||||||||||||||||||||||
Stock-based compensation and dividends, net |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
Employee stock purchase plan |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
Repurchase of common stock |
(
|
— | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||
Tax withholdings on equity awards | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
Cash dividends declared ($
|
— | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||
Balance at February 25, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
Three Months Ended | |||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||
(Dollars in millions)
(Unaudited) |
|||||||||||
Cash Flows from Operating Activities: | |||||||||||
Net income (loss)
|
$ |
|
$ |
(
|
|||||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
|||||||||||
Depreciation and amortization |
|
|
|||||||||
Goodwill impairment
|
|
|
|||||||||
Property, plant, and equipment impairment, and early lease terminations, net
|
|
|
|||||||||
Stock-based compensation |
|
|
|||||||||
Deferred income taxes
|
(
|
(
|
|||||||||
Other, net |
|
|
|||||||||
Net change in operating assets and liabilities |
(
|
|
|||||||||
Net cash provided by operating activities
|
|
|
|||||||||
Cash Flows from Investing Activities: | |||||||||||
Purchases of property, plant and equipment |
(
|
(
|
|||||||||
Payments to acquire short-term investments
|
(
|
|
|||||||||
Other investing activities, net
|
(
|
(
|
|||||||||
Net cash used for investing activities |
(
|
(
|
|||||||||
Cash Flows from Financing Activities: | |||||||||||
Repurchase of common stock |
(
|
(
|
|||||||||
Tax withholdings on equity awards |
(
|
(
|
|||||||||
Dividends to stockholders |
(
|
(
|
|||||||||
Other financing activities, net |
|
(
|
|||||||||
Net cash used for financing activities
|
(
|
(
|
|||||||||
Effect of exchange rate changes on cash and cash equivalents and restricted cash |
|
(
|
|||||||||
Net increase (decrease) in cash and cash equivalents and restricted cash
|
(
|
|
|||||||||
Beginning cash and cash equivalents
|
|
|
|||||||||
Ending cash and cash equivalents | $ |
|
$ |
|
|||||||
Noncash Investing Activity: | |||||||||||
Property, plant and equipment acquired and not yet paid at end of period | $ |
|
$ |
|
|||||||
Supplemental disclosure of cash flow information: | |||||||||||
Cash paid for income taxes during the period, net of refunds |
|
|
March 2,
2025 |
December 1,
2024 |
||||||||||
(Dollars in millions) | |||||||||||
Current Assets: | |||||||||||
Inventories | $ |
|
$ |
|
|||||||
Total current assets held for sale
|
|
|
|||||||||
Property, plant and equipment, net |
|
|
|||||||||
Operating lease right-of-use assets, net |
|
|
|||||||||
Total non-current assets held for sale
|
|
|
|||||||||
Total assets held for sale
|
$ |
|
$ |
|
|||||||
Current Liabilities: | |||||||||||
Short-term operating lease liabilities
|
$ |
|
$ |
|
|||||||
Total current liabilities held for sale
|
|
|
|||||||||
Long-term operating lease liabilities |
|
|
|||||||||
Total long-term liabilities held for sale
|
|
|
|||||||||
Total liabilities held for sale
|
$ |
|
$ |
|
Three Months Ended | |||||||||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||||||||
(Dollars in millions)
|
|||||||||||||||||||||||||||||
Net revenues | $ |
|
$ |
|
|||||||||||||||||||||||||
Cost of goods sold |
|
|
|||||||||||||||||||||||||||
Gross profit |
|
|
|||||||||||||||||||||||||||
Selling, general and administrative expenses |
|
|
|||||||||||||||||||||||||||
Restructuring charges, net
(1)
|
|
|
|||||||||||||||||||||||||||
Net loss from discontinued operations before income taxes
|
(
|
(
|
|||||||||||||||||||||||||||
Income tax benefit
|
(
|
(
|
|||||||||||||||||||||||||||
Net loss from discontinued operations, net of taxes
|
$ |
(
|
$ |
(
|
March 2, 2025 | December 1, 2024 | ||||||||||||||||||||||||||||||||||
Fair Value Estimated
Using |
Fair Value Estimated
Using |
||||||||||||||||||||||||||||||||||
Fair Value |
Level 1 Inputs
(1)
|
Level 2 Inputs
(2)
|
Fair Value |
Level 1 Inputs
(1)
|
Level 2 Inputs
(2)
|
||||||||||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||||||||||||||
Financial assets carried at fair value | |||||||||||||||||||||||||||||||||||
Rabbi trust assets | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Derivative instruments
(3)
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Financial liabilities carried at fair value | |||||||||||||||||||||||||||||||||||
Derivative instruments
(3)
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
March 2, 2025 | December 1, 2024 | ||||||||||||||||||||||
Carrying
Value |
Estimated Fair
Value |
Carrying
Value |
Estimated Fair
Value |
||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||
Financial liabilities carried at adjusted historical cost | |||||||||||||||||||||||
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
|
|
|
|
|||||||||||||||||||
Short-term borrowings |
|
|
|
|
|||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
March 2, 2025 | December 1, 2024 | ||||||||||||||||||||||||||||||||||
Assets | (Liabilities) |
Derivative
Net Carrying Value |
Assets | (Liabilities) |
Derivative
Net Carrying Value |
||||||||||||||||||||||||||||||
Carrying
Value |
Carrying
Value |
Carrying
Value |
Carrying
Value |
||||||||||||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||||||||||||||
Derivatives designated as hedging instruments
|
|||||||||||||||||||||||||||||||||||
Foreign exchange risk cash flow hedges
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Foreign exchange risk cash flow hedges
(2)
|
|
(
|
(
|
|
(
|
(
|
|||||||||||||||||||||||||||||
Total
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||
Derivatives not designated as hedging instruments
|
|||||||||||||||||||||||||||||||||||
Forward foreign exchange contracts
(1)
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||
Forward foreign exchange contracts
(2)
|
|
(
|
(
|
|
(
|
(
|
|||||||||||||||||||||||||||||
Total
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||
Non-derivatives designated as hedging instruments
|
|||||||||||||||||||||||||||||||||||
Euro senior notes
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
March 2, 2025 | December 1, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
Gross Amounts of Assets / (Liabilities)
Presented in the Balance Sheet |
Gross Amounts
Not Offset in the Balance Sheet |
Net Amounts
of Assets / (Liabilities) |
Gross Amounts of Assets / (Liabilities)
Presented in the Balance Sheet |
Gross Amounts
Not Offset in the Balance Sheet |
Net Amounts
of Assets / (Liabilities) |
|||||||||||||||||||||||||||||||||||||||||||||
(Dollars in millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||
Foreign exchange risk contracts and forward foreign exchange contracts | ||||||||||||||||||||||||||||||||||||||||||||||||||
Financial assets | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||||||||||||||
Financial liabilities |
(
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
Total | $ |
|
$ |
|
Amount of (Loss) Gain
Recognized in AOCL
(Effective Portion)
|
Amount of (Loss) Gain Reclassified from
AOCL into Net Income (Loss)
(1)
|
||||||||||||||||||||||||||||||||||
As of
March 2,
2025
|
As of
December 1,
2024
|
Three Months Ended | |||||||||||||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||||||||||||||
Foreign exchange risk contracts | $ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||||||
Realized forward foreign exchange swaps
(2)
|
|
|
|
|
|||||||||||||||||||||||||||||||
Yen-denominated Eurobonds |
(
|
(
|
|
|
|||||||||||||||||||||||||||||||
Euro-denominated senior notes |
(
|
(
|
|
|
|||||||||||||||||||||||||||||||
Cumulative income taxes |
|
|
|
|
|||||||||||||||||||||||||||||||
Total | $ |
|
$ |
(
|
Three Months Ended | |||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||
Amount of (Loss) Gain on Cash Flow Hedge Activity:
|
|||||||||||||||||||||||
Net revenues | $ |
(
|
$ |
(
|
|||||||||||||||||||
Cost of goods sold | $ |
(
|
$ |
(
|
Three Months Ended | |||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||
Forward foreign exchange contracts:
|
|||||||||||||||||||||||
Realized (loss) gain
(1)
|
$ |
(
|
$ |
|
|||||||||||||||||||
Unrealized (loss) gain
|
(
|
(
|
|||||||||||||||||||||
Total | $ |
(
|
$ |
(
|
March 2,
2025 |
December 1,
2024 |
||||||||||
(Dollars in millions) | |||||||||||
Other accrued liabilities | |||||||||||
Accrued non-trade payables | $ |
|
$ |
|
|||||||
Restructuring liabilities |
|
|
|||||||||
Accrued income taxes |
|
|
|||||||||
Accrued advertising and promotion |
|
|
|||||||||
Taxes other than income taxes payable |
|
|
|||||||||
Accrued property, plant and equipment |
|
|
|||||||||
Fair value derivatives |
|
|
|||||||||
Accrued rent |
|
|
|||||||||
Accrued interest payable |
|
|
|||||||||
Short-term debt |
|
|
|||||||||
Other |
|
|
|||||||||
Total other accrued liabilities | $ |
|
$ |
|
March 2,
2025 |
December 1,
2024 |
||||||||||
(Dollars in millions) | |||||||||||
Long-term debt | |||||||||||
|
$ |
|
$ |
|
|||||||
|
|
|
|||||||||
Total long-term debt | $ |
|
$ |
|
|||||||
Short-term debt | |||||||||||
Short-term borrowings |
|
|
|||||||||
Total debt | $ |
|
$ |
|
Three Months Ended March 2, 2025
|
|||||||||||||||||||||||||||||||||||
Liabilities |
Net Charges (Reversals)
(1)
|
Payments |
Foreign Currency Fluctuations |
Liabilities | |||||||||||||||||||||||||||||||
December 1,
2024 |
March 2,
2025 |
||||||||||||||||||||||||||||||||||
(Dollars in millions)
|
|||||||||||||||||||||||||||||||||||
Severance and employee-related benefits
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||
Contract termination costs and other
|
|
|
(
|
(
|
|
||||||||||||||||||||||||||||||
Total
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
Three Months Ended February 25, 2024
|
|||||||||||||||||||||||||||||||||||
Liabilities |
Net Charges (Reversals)
(1)
|
Payments |
Foreign Currency Fluctuations |
Liabilities | |||||||||||||||||||||||||||||||
November 26,
2023 |
February 25,
2024 |
||||||||||||||||||||||||||||||||||
(Dollars in millions)
|
|||||||||||||||||||||||||||||||||||
Severance and employee-related benefits
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||||||||
Contract termination costs and other
|
|
|
(
|
(
|
|
||||||||||||||||||||||||||||||
Total
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
Three Months Ended March 2, 2025 | |||||||||||||||||||||||||||||
Pension and
Postretirement
Benefits
(1)
|
Translation Adjustments | ||||||||||||||||||||||||||||
Derivative Instruments
(2)
|
Foreign
Currency Translation |
Total | |||||||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||||||||
Accumulated other comprehensive loss at December 1, 2024
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||
Other comprehensive (loss) income before reclassifications |
(
|
|
(
|
|
|||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive loss |
|
|
|
|
|||||||||||||||||||||||||
Net increase (decrease) in other comprehensive (loss) income |
|
|
(
|
|
|||||||||||||||||||||||||
Accumulated other comprehensive loss at March 2, 2025
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
Three Months Ended February 25, 2024 | |||||||||||||||||||||||||||||
Pension and
Postretirement
Benefits
(1)
|
Translation Adjustments | ||||||||||||||||||||||||||||
Derivative Instruments
(2)
|
Foreign
Currency Translation |
Total | |||||||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||||||||
Accumulated other comprehensive loss at November 26, 2023
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||
Other comprehensive (loss) income before reclassifications |
(
|
|
(
|
(
|
|||||||||||||||||||||||||
Amounts reclassified from accumulated other comprehensive loss |
|
|
|
|
|||||||||||||||||||||||||
Net increase (decrease) in other comprehensive income (loss) |
|
|
(
|
|
|||||||||||||||||||||||||
Accumulated other comprehensive loss at February 25, 2024
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Three Months Ended March 2, 2025 | |||||||||||||||||||||||||||||
Levi’s Brands | |||||||||||||||||||||||||||||
Americas | Europe | Asia |
Beyond Yoga
®
|
Total | |||||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||||||||
Net revenues by channel: | |||||||||||||||||||||||||||||
Wholesale | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Direct-to-consumer |
|
|
|
|
|
||||||||||||||||||||||||
Total net revenues | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended February 25, 2024 | |||||||||||||||||||||||||||||
Levi’s Brands | |||||||||||||||||||||||||||||
Americas | Europe | Asia |
Beyond Yoga
®
|
Total | |||||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||||||||
Net revenues by channel: | |||||||||||||||||||||||||||||
Wholesale | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Direct-to-consumer |
|
|
|
|
|
||||||||||||||||||||||||
Total net revenues | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended | |||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||
(Dollars in millions, except per share amounts) | |||||||||||||||||||||||
Numerator: | |||||||||||||||||||||||
Net income (loss) from continuing operations
|
$ |
|
$ |
(
|
|||||||||||||||||||
Net income (loss) from discontinued operations, net of taxes
|
(
|
(
|
|||||||||||||||||||||
Net income (loss) | $ |
|
$ |
(
|
|||||||||||||||||||
Denominator: | |||||||||||||||||||||||
Weighted-average common shares outstanding - basic |
|
|
|||||||||||||||||||||
Dilutive effect of stock awards |
|
|
|||||||||||||||||||||
Weighted-average common shares outstanding - diluted |
|
|
|||||||||||||||||||||
Earnings (loss) per common share:
|
|||||||||||||||||||||||
Continuing operations - Basic
|
$ |
|
$ |
(
|
|||||||||||||||||||
Discontinued operations - Basic
|
(
|
|
|||||||||||||||||||||
Net income (loss) - Basic
|
$ |
|
$ |
(
|
|||||||||||||||||||
Continuing operations - Diluted
|
$ |
|
$ |
(
|
|||||||||||||||||||
Discontinued operations - Diluted
|
(
|
|
|||||||||||||||||||||
Net income (loss) - Diluted
|
$ |
|
$ |
(
|
|||||||||||||||||||
Anti-dilutive securities excluded from calculation of diluted earnings (loss) per share
|
|
|
Three Months Ended | |||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||
Net revenues: | |||||||||||||||||||||||
Americas | $ |
|
$ |
|
|||||||||||||||||||
Europe |
|
|
|||||||||||||||||||||
Asia |
|
|
|||||||||||||||||||||
Total segment net revenues |
|
|
|||||||||||||||||||||
Beyond Yoga
®
|
|
|
|||||||||||||||||||||
Total net revenues | $ |
|
$ |
|
|||||||||||||||||||
Income (loss) from continuing operations before income taxes:
|
|||||||||||||||||||||||
Americas | $ |
|
$ |
|
|||||||||||||||||||
Europe |
|
|
|||||||||||||||||||||
Asia |
|
|
|||||||||||||||||||||
Total segment operating income |
|
|
|||||||||||||||||||||
Beyond Yoga operating (loss) income
|
(
|
(
|
|||||||||||||||||||||
Restructuring charges, net
(1)
|
(
|
(
|
|||||||||||||||||||||
Corporate expenses
(2)
|
(
|
(
|
|||||||||||||||||||||
Interest expense |
(
|
(
|
|||||||||||||||||||||
Other expense, net
(2)
|
(
|
(
|
|||||||||||||||||||||
Income (loss) from continuing operations before income taxes
|
$ |
|
$ |
(
|
Item 2. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
|
Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
%
Increase (Decrease) |
March 2,
2025
% of Net
Revenues
|
February 25,
2024
% of Net
Revenues
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Dollars and shares in millions, except per share amounts) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net revenues | $ | 1,526.8 | $ | 1,480.2 | 3.1 | % | 100.0 | % | 100.0 | % | |||||||||||||||||||||||||||||||||||||||||||||||||
Cost of goods sold | 579.2 | 610.4 | (5.1) | % | 37.9 | % | 41.2 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
Gross profit | 947.6 | 869.8 | 8.9 | % | 62.1 | % | 58.8 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
Selling, general and administrative expenses | 749.3 | 756.1 | (0.9) | % | 49.1 | % | 51.1 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring charges, net | 6.7 | 113.1 | (94.1) | % | 0.4 | % | 7.6 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
Operating income
|
191.6 | 0.6 | * | 12.5 | % | — | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest expense | (10.9) | (10.0) | (9.0) | % | (0.7) | % | (0.7) | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other expense, net
|
(4.1) | (2.3) | (78.3) | % | (0.3) | % | (0.2) | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
Income (loss) from continuing operations before income taxes
|
176.6 | (11.7) | * | 11.6 | % | (0.8) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Income tax expense (benefit)
|
36.4 | (1.9) | * | 2.4 | % | (0.1) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) from continuing operations
|
140.2 | (9.8) | * | 9.2 | % | (0.7) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) from discontinued operations, net of taxes
|
(5.2) | (0.8) | * | (0.3) | % | (0.1) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss)
|
$ | 135.0 | $ | (10.6) | * | 8.8 | % | (0.7) | % | ||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings (loss) per common share:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continuing operations - Basic
|
$ | 0.35 | $ | (0.03) | * | * | * | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued operations - Basic
|
(0.01) | — | * | * | * | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) - Basic
|
$ | 0.34 | $ | (0.03) | * | * | * | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Continuing operations - Diluted
|
$ | 0.35 | $ | (0.03) | * | * | * | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued operations - Diluted
|
(0.01) | — | * | * | * | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) - Diluted
|
$ | 0.34 | $ | (0.03) | * | * | * | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Weighted-average common shares outstanding
(in millions):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic | 396.6 | 398.9 | (0.6) | % | * | * | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Diluted | 400.0 | 398.9 | 0.3 | % | * | * |
Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||
% Increase (Decrease) | |||||||||||||||||||||||||||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
As
Reported |
Organic Net Revenues
|
||||||||||||||||||||||||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||||||||||||||||||||||||||
Net revenues: | |||||||||||||||||||||||||||||||||||||||||||||||
Levi’s Brands: | |||||||||||||||||||||||||||||||||||||||||||||||
Americas | $ | 783.0 | $ | 735.8 | 6.4 | % | 11.1 | % | |||||||||||||||||||||||||||||||||||||||
Europe | 400.5 | 423.5 | (5.4) | % | 2.9 | % | |||||||||||||||||||||||||||||||||||||||||
Asia | 308.1 | 288.8 | 6.7 | % | 10.0 | % | |||||||||||||||||||||||||||||||||||||||||
Total Levi’s Brands net revenues | 1,491.6 | 1,448.1 | 3.0 | % | 8.5 | % | |||||||||||||||||||||||||||||||||||||||||
Beyond Yoga
®
|
35.2 | 32.1 | 9.8 | % | 9.8 | % | |||||||||||||||||||||||||||||||||||||||||
Total net revenues | $ | 1,526.8 | $ | 1,480.2 | 3.1 | % | 8.6 | % | |||||||||||||||||||||||||||||||||||||||
Net revenues by channel: | |||||||||||||||||||||||||||||||||||||||||||||||
Wholesale | $ | 739.3 | $ | 758.4 | (2.5) | % | 4.7 | % | |||||||||||||||||||||||||||||||||||||||
DTC | 787.5 | 721.8 | 9.1 | % | 12.5 | % | |||||||||||||||||||||||||||||||||||||||||
Total net revenues | $ | 1,526.8 | $ | 1,480.2 | 3.1 | % | 8.6 | % | |||||||||||||||||||||||||||||||||||||||
Levi’s Brands net revenues:
|
|||||||||||||||||||||||||||||||||||||||||||||||
Levi’s
®
|
$ | 1,432.8 | $ | 1,385.9 | 3.4 | % | 8.2 | % | |||||||||||||||||||||||||||||||||||||||
Levi Strauss Signature
TM
|
56.5 | 47.7 | 18.4 | % | 18.9 | % | |||||||||||||||||||||||||||||||||||||||||
Denizen
®
|
2.3 | 14.5 | (84.1) | % | * | ||||||||||||||||||||||||||||||||||||||||||
Total Levi’s Brands net revenues
|
$ | 1,491.6 | $ | 1,448.1 | 3.0 | % | 8.5 | % |
Three Months Ended | |||||||||||||||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
%
Increase (Decrease) |
|||||||||||||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||||||||||||||
Net revenues | $ | 1,526.8 | $ | 1,480.2 | 3.1 | % | |||||||||||||||||||||||||||||
Cost of goods sold | 579.2 | 610.4 | (5.1) | % | |||||||||||||||||||||||||||||||
Gross profit | $ | 947.6 | $ | 869.8 | 8.9 | % | |||||||||||||||||||||||||||||
Gross margin | 62.1 | % | 58.8 | % |
Three Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
%
Increase (Decrease) |
March 2,
2025 |
February 25,
2024 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
% of Net
Revenues |
% of Net
Revenues |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Selling | $ | 330.1 | $ | 331.2 | (0.3) | % | 21.6 | % | 22.4 | % | |||||||||||||||||||||||||||||||||||||||||||||||||
Advertising and promotion | 83.4 | 81.3 | 2.6 | % | 5.5 | % | 5.5 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
Distribution
|
114.8 | 93.0 | 23.4 | % | 7.5 | % | 6.3 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other | 221.0 | 250.6 | (11.8) | % | 14.5 | % | 16.9 | % | |||||||||||||||||||||||||||||||||||||||||||||||||||
Total SG&A | $ | 749.3 | $ | 756.1 | (0.9) | % | 49.1 | % | 51.1 | % |
Three Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
%
Increase (Decrease) |
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
% of Net
Revenues |
% of Net
Revenues |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Dollars in millions) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating income (loss):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Levi’s Brands: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Americas | $ | 169.7 | $ | 132.4 | 28.2 | % | 21.7 | % | 18.0 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Europe | 102.4 | 103.5 | (1.1) | % | 25.6 | % | 24.4 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asia | 57.9 | 48.5 | 19.5 | % | 18.8 | % | 16.8 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Levi’s Brands operating income | 330.0 | 284.4 | 16.0 | % | 22.1 | % | 19.6 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Beyond Yoga
®
operating income (loss)
|
(3.1) | (0.9) | * | (8.7) | % | (2.9) | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring charges, net | (6.7) | (113.1) | 94.1 | % | (0.4) | % |
v
|
(7.6) | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate expenses | (128.6) | (169.8) | 24.3 | % | (8.4) | % |
v
|
(11.5) | % | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total operating income
|
$ | 191.6 | $ | 0.6 | * | 12.5 | % |
v
|
— | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Operating margin | 12.5 | % | — | % |
Three Months Ended | |||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||
(Dollars in millions) | |||||||||||
Cash provided by operating activities
|
$ | 52.5 | $ | 286.0 | |||||||
Cash used for investing activities | (71.1) | (71.7) | |||||||||
Cash used for financing activities
|
(97.5) | (94.5) | |||||||||
Cash and cash equivalents at period end | 574.4 | 516.7 |
Most comparable GAAP measure | Non-GAAP measure | Non-GAAP measure definition | ||||||||||||
Selling, general and administrative (“SG&A”) expenses
|
Adjusted SG&A |
SG&A expenses excluding goodwill impairment charges, restructuring related charges, severance and other, net and acquisition and integration related charges
|
||||||||||||
SG&A margin | Adjusted SG&A margin | Adjusted SG&A as a percentage of net revenues | ||||||||||||
Net income (loss) from continuing operations
|
Adjusted EBIT
|
Net income (loss) from continuing operations excluding income tax expense (benefit), interest expense, other expense, net, goodwill impairment charges, restructuring charges, net, restructuring related charges, severance and other, net and acquisition and integration related charges
|
||||||||||||
Net income (loss) margin from continuing operations
|
Adjusted EBIT margin
|
Adjusted EBIT as a percentage of net revenues
|
||||||||||||
Net income (loss) from continuing operations
|
Adjusted EBITDA
|
Adjusted EBIT excluding depreciation and amortization expense
|
||||||||||||
Net income (loss) from continuing operations
|
Adjusted net income
|
Net income (loss) from continuing operations excluding goodwill impairment charges, restructuring charges, net, restructuring related charges, severance and other, net, and acquisition and integration related charges adjusted to give effect to the income tax impact of such adjustments
|
||||||||||||
Net income (loss) margin from continuing operations
|
Adjusted net income margin
|
Adjusted net income as a percentage of net revenues
|
||||||||||||
Diluted earnings (loss) per share from continuing operations
|
Adjusted diluted earnings per share
|
Adjusted net income per weighted-average number of diluted common shares outstanding
|
Three Months Ended | |||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||
Most comparable GAAP measure: | |||||||||||||||||||||||
Selling, general and administrative expenses | $ | 749.3 | $ | 756.1 | |||||||||||||||||||
Non-GAAP measure: | |||||||||||||||||||||||
Selling, general and administrative expenses | $ | 749.3 | $ | 756.1 | |||||||||||||||||||
Goodwill impairment charges
(1)
|
(2.5) | (5.5) | |||||||||||||||||||||
Restructuring related charges, severance and other, net
(2)
|
(3.2) | (15.4) | |||||||||||||||||||||
Acquisition and integration related charges
(3)
|
— | (4.0) | |||||||||||||||||||||
Adjusted SG&A | $ | 743.6 | $ | 731.2 | |||||||||||||||||||
SG&A margin | 49.1 | % | 51.1 | % | |||||||||||||||||||
Adjusted SG&A margin | 48.7 | % | 49.4 | % |
(1) | For the three-month period ended March 2, 2025, goodwill impairment charges includes the recognition of a $2.5 million goodwill impairment charge related to our business in Bolivia. | ||||
For the three-month period ended February 25, 2024, goodwill impairment charges includes the recognition of a $5.5 million goodwill impairment charge related to our footwear business. | |||||
(2) | For the three-month period ended March 2, 2025, restructuring related charges, severance, and other, net primarily relates to consulting costs associated with our restructuring initiative of $2.1 million. | ||||
For the three-month period ended February 25, 2024, restructuring related charges, severance, and other, net primarily relates to consulting costs associated with our restructuring initiative of $10.1 million, other executive separation charges and legal settlements of $3.7 million and transaction and deal related costs of $1.0 million. | |||||
(3) | Acquisition and integration related charges includes acquisition-related compensation subject to the continued employment of certain Beyond Yoga® employees. In the first quarter of 2024, their employment ceased, resulting in the acceleration of the remaining compensation. |
Three Months Ended | |||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||
Most comparable GAAP measure: | |||||||||||||||||||||||
Net income (loss) from continuing operations | $ | 140.2 | $ | (9.8) | |||||||||||||||||||
Non-GAAP measure: | |||||||||||||||||||||||
Net income (loss) from continuing operations | $ | 140.2 | $ | (9.8) | |||||||||||||||||||
Income tax expense (benefit)
|
36.4 | (1.9) | |||||||||||||||||||||
Interest expense | 10.9 | 10.0 | |||||||||||||||||||||
Other expense, net
|
4.1 | 2.3 | |||||||||||||||||||||
Goodwill impairment charges
(1)
|
2.5 | 5.5 | |||||||||||||||||||||
Restructuring charges, net
(2)
|
6.7 | 113.1 | |||||||||||||||||||||
Restructuring related charges, severance and other, net
(3)
|
3.2 | 15.4 | |||||||||||||||||||||
Acquisition and integration related charges
(4)
|
— | 4.0 | |||||||||||||||||||||
Adjusted EBIT
|
$ | 204.0 | $ | 138.6 | |||||||||||||||||||
Depreciation and amortization
|
49.1 | 43.5 | |||||||||||||||||||||
Adjusted EBITDA
|
$ | 253.1 | $ | 182.1 | |||||||||||||||||||
Net income (loss) margin from continuing operations
|
9.2 | % | (0.7) | % | |||||||||||||||||||
Adjusted EBIT margin
|
13.4 | % | 9.4 | % |
(1) | For the three-month period ended March 2, 2025, goodwill impairment charges includes the recognition of a $2.5 million goodwill impairment charge related to our business in Bolivia. | ||||
For the three-month period ended February 25, 2024, goodwill impairment charges includes the recognition of a $5.5 million goodwill impairment charge related to our footwear business. | |||||
(2) | For the three-month period ended March 2, 2025, restructuring charges, net includes $6.7 million in connection with Project Fuel consisting primarily of severance, post-employment benefit charges, contract terminations and asset impairments. | ||||
For the three-month period ended February 25, 2024, restructuring charges, net includes $113.1 million in connection with Project Fuel consisting primarily of severance and other post-employment benefit charges. | |||||
(3) | For the three-month period ended March 2, 2025, restructuring related charges, severance, and other, net primarily relates to consulting costs associated with our restructuring initiative of $2.1 million. | ||||
For the three-month period ended February 25, 2024, restructuring related charges, severance, and other, net primarily relates to consulting costs associated with our restructuring initiative of $10.1 million, other executive separation charges and legal settlements of $3.7 million and transaction and deal related costs of $1.0 million. | |||||
(4) | Acquisition and integration related charges includes acquisition-related compensation subject to the continued employment of certain Beyond Yoga® employees. In the first quarter of 2024, their employment ceased, resulting in the acceleration of the remaining compensation. |
Three Months Ended | |||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||
Most comparable GAAP measure: | |||||||||||||||||||||||
Net income (loss) from continuing operations
|
$ | 140.2 | $ | (9.8) | |||||||||||||||||||
Non-GAAP measure: | |||||||||||||||||||||||
Net income (loss) from continuing operations
|
$ | 140.2 | $ | (9.8) | |||||||||||||||||||
Goodwill impairment charges
(1)
|
2.5 | 5.5 | |||||||||||||||||||||
Restructuring charges, net
(2)
|
6.7 | 113.1 | |||||||||||||||||||||
Restructuring related charges, severance and other, net
(3)
|
3.2 | 15.4 | |||||||||||||||||||||
Acquisition and integration related charges
(4)
|
— | 4.0 | |||||||||||||||||||||
Tax impact of adjustments
(5)
|
(2.6) | (27.8) | |||||||||||||||||||||
Adjusted net income
|
$ | 150.0 | $ | 100.4 | |||||||||||||||||||
Net income (loss) margin from continuing operations
|
9.2 | % | (0.7) | % | |||||||||||||||||||
Adjusted net income margin
|
9.8 | % | 6.8 | % |
(1) | For the three-month period ended March 2, 2025, goodwill impairment charges includes the recognition of a $2.5 million goodwill impairment charge related to our business in Bolivia. | ||||
For the three-month period ended February 25, 2024, goodwill impairment charges includes the recognition of a $5.5 million goodwill impairment charge related to our footwear business. | |||||
(2) | For the three-month period ended March 2, 2025, restructuring charges, net includes $6.7 million in connection with Project Fuel consisting primarily of severance, post-employment benefit charges, contract terminations and asset impairments. | ||||
For the three-month period ended February 25, 2024, restructuring charges, net includes $113.1 million in connection with Project Fuel consisting primarily of severance and other post-employment benefit charges. | |||||
(3) | For the three-month period ended March 2, 2025, restructuring related charges, severance, and other, net primarily relates to consulting costs associated with our restructuring initiative of $2.1 million. | ||||
For the three-month period ended February 25, 2024, restructuring related charges, severance, and other, net primarily relates to consulting costs associated with our restructuring initiative of $10.1 million, other executive separation charges and legal settlements of $3.7 million and transaction and deal related costs of $1.0 million. | |||||
(4) | Acquisition and integration related charges includes acquisition-related compensation subject to the continued employment of certain Beyond Yoga® employees. In the first quarter of 2024, their employment ceased, resulting in the acceleration of the remaining compensation. | ||||
(5) | Tax impact calculated using the annual effective tax rate, excluding discrete costs and benefits. |
Three Months Ended | |||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||
Most comparable GAAP measure: | |||||||||||||||||||||||
Diluted earnings (loss) per share from continuing operations
|
$ | 0.35 | $ | (0.03) | |||||||||||||||||||
Non-GAAP measure: | |||||||||||||||||||||||
Diluted earnings (loss) per share from continuing operations
(1)
|
$ | 0.35 | $ | (0.03) | |||||||||||||||||||
Goodwill impairment charges
(2)
|
0.01 | 0.02 | |||||||||||||||||||||
Restructuring charges, net
(3)
|
0.02 | 0.28 | |||||||||||||||||||||
Restructuring related charges, severance and other, net
(4)
|
0.01 | 0.04 | |||||||||||||||||||||
Acquisition and integration related charges
(5)
|
— | 0.01 | |||||||||||||||||||||
Tax impact of adjustments
(6)
|
(0.01) | (0.07) | |||||||||||||||||||||
Adjusted diluted earnings per share
|
$ | 0.38 | $ | 0.25 |
(1) | For the three-month period ended February 25, 2024, 398.9 million shares were used in the calculation of diluted loss per share and 402.6 million were used in the calculation of adjusted diluted earnings per share. The dilutive effect of stock awards of 3.6 million were not included in the calculation of diluted loss per share as the inclusion of these securities would have been anti-dilutive. | ||||
(2) | For the three-month period ended March 2, 2025, goodwill impairment charges includes the recognition of a $2.5 million goodwill impairment charge related to our business in Bolivia. | ||||
For the three-month period ended February 25, 2024, goodwill impairment charges includes the recognition of a $5.5 million goodwill impairment charge related to our footwear business. | |||||
(3) | For the three-month period ended March 2, 2025, restructuring charges, net includes $6.7 million in connection with Project Fuel consisting primarily of severance, post-employment benefit charges, contract terminations and asset impairments. | ||||
For the three-month period ended February 25, 2024, restructuring charges, net includes $113.1 million in connection with Project Fuel consisting primarily of severance and other post-employment benefit charges. | |||||
(4) | For the three-month period ended March 2, 2025, restructuring related charges, severance, and other, net primarily relates to consulting costs associated with our restructuring initiative of $2.1 million. | ||||
For the three-month period ended February 25, 2024, restructuring related charges, severance, and other, net primarily relates to consulting costs associated with our restructuring initiative of $10.1 million, other executive separation charges and legal settlements of $3.7 million and transaction and deal related costs of $1.0 million. | |||||
(5) | Acquisition and integration related charges includes acquisition-related compensation subject to the continued employment of certain Beyond Yoga® employees. In the first quarter of 2024, their employment ceased, resulting in the acceleration of the remaining compensation. | ||||
(6) | Tax impact calculated using the annual effective tax rate, excluding discrete costs and benefits. |
Three Months Ended | |||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||
Most comparable GAAP measure: | |||||||||||||||||||||||
Net cash provided by operating activities
|
$ | 52.5 | $ | 286.0 | |||||||||||||||||||
Net cash used for investing activities | (71.1) | (71.7) | |||||||||||||||||||||
Net cash used for financing activities
|
(97.5) | (94.5) | |||||||||||||||||||||
Non-GAAP measure: | |||||||||||||||||||||||
Net cash provided by operating activities
|
$ | 52.5 | $ | 286.0 | |||||||||||||||||||
Purchases of property, plant and equipment | (66.6) | (71.6) | |||||||||||||||||||||
Adjusted free cash flow | $ | (14.1) | $ | 214.4 | |||||||||||||||||||
Three Months Ended | |||||||||||||||||
March 2,
2025 |
February 25,
2024 |
% Increase
(Decrease) |
|||||||||||||||
(Dollars in millions) | |||||||||||||||||
(Unaudited)
|
|||||||||||||||||
Total net revenues
(1)
|
|||||||||||||||||
As reported | $ | 1,526.8 | $ | 1,480.2 | 3.1 | % | |||||||||||
Impact of foreign currency exchange rates | — | (45.9) | |||||||||||||||
Net revenues from Denizen
®
divestiture
|
(2.3) | (14.2) | |||||||||||||||
Net revenues from Footwear category divestiture
|
— | (16.0) | |||||||||||||||
Organic net revenues | $ | 1,524.5 | $ | 1,404.1 | 8.6 | % | |||||||||||
Americas | |||||||||||||||||
As reported | $ | 783.0 | $ | 735.8 | 6.4 | % | |||||||||||
Impact of foreign currency exchange rates | — | (18.8) | |||||||||||||||
Net revenues from Denizen
®
divestiture
|
(2.3) | (14.2) | |||||||||||||||
Organic net revenues - Americas | $ | 780.7 | $ | 702.8 | 11.1 | % | |||||||||||
Europe | |||||||||||||||||
As reported | $ | 400.5 | $ | 423.5 | (5.4) | % | |||||||||||
Impact of foreign currency exchange rates | — | (18.4) | |||||||||||||||
Net revenues from Footwear category divestiture
|
— | (16.0) | |||||||||||||||
Organic net revenues - Europe | $ | 400.5 | $ | 389.1 | 2.9 | % | |||||||||||
Asia | |||||||||||||||||
As reported | $ | 308.1 | $ | 288.8 | 6.7 | % | |||||||||||
Impact of foreign currency exchange rates | — | (8.7) | |||||||||||||||
Organic net revenues - Asia | $ | 308.1 | $ | 280.1 | 10.0 | % | |||||||||||
Beyond Yoga
®
|
|||||||||||||||||
As reported | $ | 35.2 | $ | 32.1 | 9.8 | % | |||||||||||
Organic net revenues - Beyond Yoga
®
|
$ | 35.2 | $ | 32.1 | 9.8 | % |
(1) |
These measures exclude the results of our Dockers
®
business, which is classified as discontinued operations.
|
Three Months Ended | |||||||||||||||||
March 2,
2025 |
February 25,
2024 |
% Increase
(Decrease) |
|||||||||||||||
(Dollars in millions) | |||||||||||||||||
Total net revenues
(1)
|
|||||||||||||||||
As reported | $ | 1,526.8 | $ | 1,480.2 | 3.1 | % | |||||||||||
Impact of foreign currency exchange rates | — | (45.9) | |||||||||||||||
Net revenues from Denizen
®
divestiture
|
(2.3) | (14.2) | |||||||||||||||
Net revenues from Footwear category divestiture
|
— | (16.0) | |||||||||||||||
Organic net revenues | $ | 1,524.5 | $ | 1,404.1 | 8.6 | % | |||||||||||
Wholesale
|
|||||||||||||||||
As reported | $ | 739.3 | $ | 758.4 | (2.5) | % | |||||||||||
Impact of foreign currency exchange rates | — | (24.1) | |||||||||||||||
Net revenues from Denizen
®
divestiture
|
(2.3) | (14.2) | |||||||||||||||
Net revenues from Footwear category divestiture
|
— | (16.0) | |||||||||||||||
Organic net revenues - Wholesale
|
$ | 737.0 | $ | 704.1 | 4.7 | % | |||||||||||
DTC
|
|||||||||||||||||
As reported | $ | 787.5 | $ | 721.8 | 9.1 | % | |||||||||||
Impact of foreign currency exchange rates | — | (21.8) | |||||||||||||||
Organic net revenues - DTC
|
$ | 787.5 | $ | 700.0 | 12.5 | % |
(1) |
These measures exclude the results of our Dockers
®
business, which is classified as discontinued operations.
|
Three Months Ended | |||||||||||||||||
March 2,
2025 |
February 25,
2024 |
% Increase
(Decrease) |
|||||||||||||||
(Dollars in millions) | |||||||||||||||||
Total Levi’s Brands net revenues
(1)
|
|||||||||||||||||
As reported | $ | 1,491.6 | $ | 1,448.1 | 3.0 | % | |||||||||||
Impact of foreign currency exchange rates | — | (45.9) | |||||||||||||||
Net revenues from Denizen
®
divestiture
|
(2.3) | (14.2) | |||||||||||||||
Net revenues from Footwear category divestiture
|
— | (16.0) | |||||||||||||||
Organic net revenues | $ | 1,489.3 | $ | 1,372.0 | 8.5 | % | |||||||||||
Levi’s
®
|
|||||||||||||||||
As reported | $ | 1,432.8 | $ | 1,385.9 | 3.4 | % | |||||||||||
Impact of foreign currency exchange rates | — | (45.4) | |||||||||||||||
Net revenues from Footwear category divestiture
|
— | (16.0) | |||||||||||||||
Organic net revenues - Levi’s
®
|
$ | 1,432.8 | $ | 1,324.5 | 8.2 | % | |||||||||||
Levi Strauss Signature
TM
|
|||||||||||||||||
As reported | $ | 56.5 | $ | 47.7 | 18.4 | % | |||||||||||
Impact of foreign currency exchange rates
|
— | (0.2) | |||||||||||||||
Organic net revenues - Levi Strauss Signature
TM
|
$ | 56.5 | $ | 47.5 | 18.9 | % | |||||||||||
Denizen
®
|
|||||||||||||||||
As reported | $ | 2.3 | $ | 14.5 | (84.1) | % | |||||||||||
Impact of foreign currency exchange rates
|
— | (0.3) | |||||||||||||||
Net revenues from Denizen
®
divestiture
|
(2.3) | (14.2) | |||||||||||||||
Organic net revenues - Denizen
®
|
$ | — | $ | — | * |
(1) |
These measures exclude the results of our Dockers
®
business, which is classified as discontinued operations.
|
Three Months Ended | |||||||||||||||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
%
Increase
(Decrease)
|
|||||||||||||||||||||||||||||||||
(Dollars in millions) | |||||||||||||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||||||||||||
Adjusted EBIT
(1)
|
$ | 204.0 | $ | 138.6 | 47.2 | % | |||||||||||||||||||||||||||||
Impact of foreign currency exchange rates | — | (9.7) | * | ||||||||||||||||||||||||||||||||
Constant-currency Adjusted EBIT
|
$ | 204.0 | $ | 128.9 | 58.2 | % | |||||||||||||||||||||||||||||
Adjusted EBIT margin
|
13.4 | % | 9.4 | % | 42.6 | % | |||||||||||||||||||||||||||||
Impact of foreign currency exchange rates | — | (0.4) | * | ||||||||||||||||||||||||||||||||
Constant-currency Adjusted EBIT margin
(2)
|
13.4 | % | 9.0 | % | 48.9 | % |
(1) |
Adjusted EBIT is reconciled from net income (loss) from continuing operations which is the most comparable GAAP measure. Refer to Adjusted EBIT and Adjusted EBITDA table for more information.
|
||||
(2) |
We define constant-currency Adjusted EBIT margin as constant-currency Adjusted EBIT as a percentage of constant-currency net revenues.
|
Three Months Ended | |||||||||||||||||||||||||||||||||||
March 2,
2025 |
February 25,
2024 |
%
Increase
(Decrease)
|
|||||||||||||||||||||||||||||||||
(Dollars in millions, except per share amounts) | |||||||||||||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||||||||||||
Adjusted net income
(1)
|
$ | 150.0 | $ | 100.4 | 49.4 | % | |||||||||||||||||||||||||||||
Impact of foreign currency exchange rates | — | (5.4) | * | ||||||||||||||||||||||||||||||||
Constant-currency Adjusted net income
|
$ | 150.0 | $ | 95.0 | 57.9 | % | |||||||||||||||||||||||||||||
Constant-currency Adjusted net income margin
(2)
|
9.8 | % | 6.6 | % | |||||||||||||||||||||||||||||||
Adjusted diluted earnings per share
|
$ | 0.38 | $ | 0.25 | 52.0 | % | |||||||||||||||||||||||||||||
Impact of foreign currency exchange rates | — | (0.01) | * | ||||||||||||||||||||||||||||||||
Constant-currency Adjusted diluted earnings per share
|
$ | 0.38 | $ | 0.24 | 58.3 | % |
(1) |
Adjusted net income is reconciled from net income (loss) from continuing operations which is the most comparable GAAP measure. Refer to Adjusted net income table for more information.
|
||||
(2) |
We define constant-currency Adjusted net income margin as constant-currency Adjusted net income as a percentage of constant-currency net revenues.
|
Year Ended December 1, 2024
|
|||||||||||||||||||||||||||||
First
Quarter
|
Second
Quarter
|
Third
Quarter
|
Fourth
Quarter
|
Full-Year
|
|||||||||||||||||||||||||
(Dollars and shares in millions, except per share amounts)
(Unaudited)
|
|||||||||||||||||||||||||||||
Net revenues | $ | 1,480.2 | $ | 1,358.8 | $ | 1,443.1 | $ | 1,749.9 | $ | 6,032.0 | |||||||||||||||||||
Cost of goods sold | 610.4 | 526.4 | 569.2 | 668.9 | 2,374.9 | ||||||||||||||||||||||||
Gross profit | 869.8 | 832.4 | 873.9 | 1,081.0 | 3,657.1 | ||||||||||||||||||||||||
Selling, general and administrative expenses | 750.6 | 756.4 | 726.4 | 858.5 | 3,091.9 | ||||||||||||||||||||||||
Restructuring charges, net | 113.1 | 55.1 | 3.4 | 14.0 | 185.6 | ||||||||||||||||||||||||
Goodwill and other intangible asset impairment charges
|
5.5 | — | 111.4 | — | 116.9 | ||||||||||||||||||||||||
Operating income
|
0.6 | 20.9 | 32.7 | 208.5 | 262.7 | ||||||||||||||||||||||||
Interest expense | (10.0) | (10.3) | (10.1) | (11.4) | (41.8) | ||||||||||||||||||||||||
Other income (expense), net
|
(2.3) | 0.4 | (0.4) | (1.0) | (3.3) | ||||||||||||||||||||||||
Income (loss) from continuing operations before income taxes
|
(11.7) | 11.0 | 22.2 | 196.1 | 217.6 | ||||||||||||||||||||||||
Income tax expense (benefit)
|
(1.9) | (6.2) | (0.5) | 15.8 | 7.2 | ||||||||||||||||||||||||
Net income (loss) from continuing operations
|
(9.8) | 17.2 | 22.7 | 180.3 | 210.4 | ||||||||||||||||||||||||
Net income (loss) from discontinued operations, net of taxes
|
(0.8) | 0.8 | (2.0) | 2.2 | 0.2 | ||||||||||||||||||||||||
Net income (loss)
|
$ | (10.6) | $ | 18.0 | $ | 20.7 | $ | 182.5 | $ | 210.6 | |||||||||||||||||||
Earnings (loss) per common share:
|
|||||||||||||||||||||||||||||
Continuing operations - Basic
|
$ | (0.03) | $ | 0.04 | $ | 0.06 | $ | 0.45 | $ | 0.53 | |||||||||||||||||||
Discontinued operations - Basic
|
— | — | (0.01) | 0.01 | — | ||||||||||||||||||||||||
Net income (loss) - Basic
|
$ | (0.03) | $ | 0.05 | $ | 0.05 | $ | 0.46 | $ | 0.53 | |||||||||||||||||||
Continuing operations - Diluted
|
$ | (0.03) | $ | 0.04 | $ | 0.06 | $ | 0.45 | $ | 0.52 | |||||||||||||||||||
Discontinued operations - Diluted
|
— | — | — | 0.01 | — | ||||||||||||||||||||||||
Net income (loss) - Diluted
|
$ | (0.03) | $ | 0.04 | $ | 0.05 | $ | 0.46 | $ | 0.52 | |||||||||||||||||||
Weighted-average common shares outstanding: | |||||||||||||||||||||||||||||
Basic | 398.9 | 398.8 | 398.2 | 397.1 | 398.2 | ||||||||||||||||||||||||
Diluted | 398.9 | 402.9 | 402.4 | 401.0 | 402.4 |
Year Ended December 1, 2024
|
|||||||||||||||||||||||||||||
First
Quarter
|
Second
Quarter
|
Third
Quarter
|
Fourth
Quarter
|
Full-Year
|
|||||||||||||||||||||||||
(Dollars and shares in millions, except per share amounts)
(Unaudited)
|
|||||||||||||||||||||||||||||
Net revenues | $ | 77.4 | $ | 82.4 | $ | 73.7 | $ | 89.8 | $ | 323.3 | |||||||||||||||||||
Cost of goods sold | 40.7 | 43.1 | 36.9 | 43.8 | 164.5 | ||||||||||||||||||||||||
Gross profit | 36.7 | 39.3 | 36.8 | 46.0 | 158.8 | ||||||||||||||||||||||||
Selling, general and administrative expenses | 34.6 | 38.3 | 39.2 | 42.2 | 154.3 | ||||||||||||||||||||||||
Restructuring charges, net | 3.1 | — | — | — | 3.1 | ||||||||||||||||||||||||
Net income (loss) from discontinued operations before income taxes
|
(1.0) | 1.0 | (2.4) | 3.8 | 1.4 | ||||||||||||||||||||||||
Income tax expense (benefit) | (0.2) | 0.2 | (0.4) | 1.6 | 1.2 | ||||||||||||||||||||||||
Net income (loss) from discontinued operations, net of taxes
|
$ | (0.8) | $ | 0.8 | $ | (2.0) | $ | 2.2 | $ | 0.2 |
Item 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
Item 4. | CONTROLS AND PROCEDURES |
Item 1. | LEGAL PROCEEDINGS |
Item 1A. | RISK FACTORS |
Item 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
Period |
Total number of shares purchased
(1)
|
Average price paid per share
(2)
|
Total number of shares purchased as part of publicly announced plans or programs
(1)
|
Approximate maximum dollar value of shares that may yet be purchased under the plans or programs
(1)
|
|||||||||||||||||||
December 2, 2024 - January 5, 2025
|
— | $ | — | — | $ | 590,436,523 | |||||||||||||||||
January 6, 2025 - February 2, 2025
|
105,314 | 19.19 | 105,314 | $ | 588,415,705 | ||||||||||||||||||
February 3, 2025 - March 2, 2025
|
1,520,838 | 18.40 | 1,520,838 | $ | 560,436,556 | ||||||||||||||||||
Total | 1,626,152 | $ | 18.45 | 1,626,152 |
Item 3. | DEFAULTS UPON SENIOR SECURITIES |
Item 4. | MINE SAFETY DISCLOSURES |
Item 5.
|
OTHER INFORMATION
|
Name and Title
|
Action
|
Applicable Date
|
Duration of Trading Arrangements
|
Rule 10b5-1 Trading Arrangement?
(Y/N)*
|
Aggregate Number of Securities Subject to Trading Arrangement
|
||||||||||||
|
|
|
February 12, 2025 - February 11, 2026
|
Y |
Up to
|
Item 6. | EXHIBITS |
Incorporated by Reference | ||||||||||||||||||||||||||||||||
Exhibit Number | Description of Document | Form | SEC File No. | Exhibit | Filing Date | |||||||||||||||||||||||||||
3.1 | 8-K | 001-06631 | 3.1 | 3/25/2019 | ||||||||||||||||||||||||||||
3.2 | 8-K | 001-06631 | 3.1 | 4/21/2023 | ||||||||||||||||||||||||||||
31.1 | ||||||||||||||||||||||||||||||||
31.2 | ||||||||||||||||||||||||||||||||
32.1† | ||||||||||||||||||||||||||||||||
101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. Filed herewith. | |||||||||||||||||||||||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document. Filed herewith. | |||||||||||||||||||||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. Filed herewith. | |||||||||||||||||||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. Filed herewith. | |||||||||||||||||||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. Filed herewith. | |||||||||||||||||||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. Filed herewith. | |||||||||||||||||||||||||||||||
104 |
Cover Page Interactive Data File (formatted as inline XBRL and contained within Exhibit 101). Filed herewith.
|
|||||||||||||||||||||||||||||||
Date: | April 7, 2025 | LEVI STRAUSS & CO. | |||||||||
(Registrant) | |||||||||||
By: | /s/ LISA W. STIRLING | ||||||||||
Lisa W. Stirling
Senior Vice President and Global Controller |
|||||||||||
(Principal Accounting Officer and Duly Authorized Officer) |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
The Gap, Inc. | GPS |
Nordstrom, Inc. | JWN |
Ross Stores, Inc. | ROST |
The TJX Companies, Inc. | TJX |
Suppliers
Supplier name | Ticker |
---|---|
Expeditors International of Washington, Inc. | EXPD |
Eastman Chemical Company | EMN |
Matson, Inc. | MATX |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|